This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
 
Mid-Term Elections, Key Jobs Data, Earnings in Focus for the Week Ahead

The market made a big comeback this week, with the S&P 500 back over 2000.

Jim Cramer Says Forego Chevron and Exxon for Royal Dutch Shell

Jim Cramer says oil is moving lower because of oversupply. He says that's why Exxon and Chevron are not a buy.

WPP Chief Sees $3B in Spending on Google, $650M on Facebook in 2015

WPP's CEO Martin Sorrell says geopolitical concerns like Ebola, ISIL, tensions between Russia and Ukraine and the conflict in Hong Kong is having a spill-over effect on business confidence.

Starbucks Shares Fall on Revenue Miss, Present Buying Opportunity

Shares of Starbucks fell in Friday trading after the company reported fiscal fourth-quarter revenue that missed expectations after the prior session's close.

Citigroup Forced to Lower Quarterly Results as Legal Costs Weigh

Citigroup announced it's adjusting its third quarter results downward as it sets aside an additional $600 million to cover legal expenses.

Real Money Previews

Cramer on the Stock Market: Find the Best of Best-of-Breed Stocks

Remember these franchises and who captains them.

Real Money's Eric Jackson: Is Alibaba About to Go Hollywood?

Searching for online content, Jack Ma of Alibaba is making the rounds in California.

Jim Cramer on Technology Stocks: Trust Facebook, Here's Why

Yes, Facebook spends a lot. But it's for a purpose.

Mad Money Recap

Jim Cramer's 'Mad Money' Recap: How to Manage Your Financial Life

Sometimes you have to step back and talk about the big picture when it comes to investing, Cramer says.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to find the stocks he and Stephanie Link think could be HUGE winners. Click here to see them for FREE.

Stock Ideas

5 Breakout Stocks Under $10 Set to Soar

These under-$10 stocks look ready to break out and trade higher from current levels.

Sell These 5 Scary Stocks Before It's Too Late

It's time to unload these toxic stocks from your portfolio.

4 Stocks Under $10 Making Big Moves Higher

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

5 Big Stocks to Trade for Gains as QE3 Ends

Here's how to trade some of the biggest Stocks on Wall Street as the Fed calls for an end to quantitative easing.

4 Stocks Breaking Out on Big Volume

These stocks rising on unusual volume are within range of triggering breakout trades.

MainStreet

Student Loan Servicers Deceived Borrowers and Manipulated Payments to Maximize Late Fees

A new report by the CFPB catches student loan servicers maximizing late fees and lying about minimum payments.

75% of Consumers Have Debt, Survey Says: But How Much Does Debt Cost?

A new survey sheds light on how many consumers are plagued by burdensome debt and how expensive debt can be.

The Ultimate Cannabis Buyer's Guide: A Dozen Ways to Spend $500 on Marijuana

Main Street's whistleblower Brian Penny explains how to invest $500 in marijuana

The Airfare Flash Deal Face-off: Airfarewatchdog vs. The FlightDeal

Terrific airfare bargains are there for the grabbing at the right websites

Paid Time Off: Is It an Employee Benefit or an Old-fashioned Con?

PTO is sweeping the workplace. But who benefits? Workers or bosses?

Biotech

Biotech Stock Mailbag: Prosensa, Sarepta, Arena Pharma, Hemispherx

Biotech columnist Adam Feuerstein answers readers' questions about health care.

Aegerion Problems Mount With Poor Quarter and Reduced Guidance

The accusations of cocaine use and having sex with someone else's wife are the least of Marc Beer's problems. Aegerion Pharmaceuticals, the company he runs as CEO, is falling apart.

Aegerion Board Expresses Support for Embattled CEO Amid Drug Use Accusations

Aegerion Pharmaceuticals issued a statement Tuesday night expressing its board's support for CEO Marc Beer in the face of accusations of cocaine use and extramarital sex.

Beyond Wall St.

Deal News

The Untouchables: Where Even Activist Investors Fear to Tread

Up to now, companies in highly regulated industries were safe from activists.

Dollar General Keeps Up the Pressure in the Fight for Family Dollar

Dollar General is continuing its determined pursuit of rival discount retailer Family Dollar Stores.

Dollar General Once Again Extends Family Dollar Tender Offer

Plans to file a proxy statement ahead of target's special meeting to vote on agreed Dollar Tree deal.

TheStreetTV
Spin Space

Jim Cramer

Jim Cramer Says Forego Chevron and Exxon for Royal Dutch Shell

Jim Cramer says oil is moving lower because of oversupply. He says that's why Exxon and Chevron are not a buy.

Herb Greenberg

Herb Greenberg on the Stock Market: Is Coke the New IBM?

I can't remember a time when so many big brands stumbled.

Stephanie Link

Panera Bread Lunches Out Following Earnings but Stephanie Link is a Buyer

Panera Bread is under pressure following earnings, beating on the bottom line, coming in line on the top, guiding down Q4 and not providing guidance for 20145.

Chris Ciaccia

Glu Mobile Gets Unglued Amid Weaker Forecast, Harman International Jumps: Tech Winners & Losers

Glu Mobile cratered Thursday after the mobile games publisher issued a weaker-than-expected forecast. But Harman International Industries soared on earnings strength and demand for...

Adam Feuerstein

Biotech Stock Mailbag: Prosensa, Sarepta, Arena Pharma, Hemispherx

Biotech columnist Adam Feuerstein answers readers' questions about health care.

Dan Freed

Hedge Fund Billionaires Support New York Attorney General Schneiderman

Chanos, Einhorn, Soros and Paulson are some of the prominent hedge fund names who are backing Schneiderman's 2014 reelection campaign.

Ted Reed

Alaska Airlines Is Downgraded Because of Delta's Seattle Incursion

Alaska Airlines shares have gained 44% this year, mid-range for airline stocks, and a leading airline analyst says Delta's Seattle buildup is bound to hurt the stock.

Leon Lazaroff

Tim Cook’s Gay Declaration Needs a Whole Lot More CEO Support

Tim Cook's declaration may encourage other CEOs and employees to come out as gay in the workplace, but it's easier to be out if you run a company like Apple.

Submit an article to us!
DOW 17,390.52 +195.10 1.13%
S&P 500 2,018.05 -2.75 -0.14%
NASDAQ 4,630.7410 +64.6030 1.41%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs